![Sebastien Maloveste](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sebastien Maloveste
Corporate Officer/Principal chez
NEXTCURE, INC.
Profil
Sebastien Maloveste currently works at NextCure, Inc., as Senior Vice President-Business Development.
Dr. Maloveste also formerly worked at GenVec, Inc., as Director-Business Development from 2015 to 2017 and Amplimmune, Inc., as Associate Director-Business Development in 2015.
Dr. Maloveste received his doctorate degree from Universite De La Mediterranee.
Postes actifs de Sebastien Maloveste
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCURE, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Sebastien Maloveste
| Sociétés | Poste | Fin |
|---|---|---|
| GENVEC INC | Corporate Officer/Principal | 01/06/2017 |
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Corporate Officer/Principal | 01/09/2015 |
Formation de Sebastien Maloveste
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Universite De La Mediterranee
 Universite De La Mediterranee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
